Sight Sciences, Inc. financial data

Symbol
SGHT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4040 Campbell Ave,, Suite 100, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % -16.5%
Quick Ratio 48.1 % -16.6%
Debt-to-equity 50.4 % +36.7%
Return On Equity -52.4 % -24.9%
Return On Assets -34.8 % -13.6%
Operating Margin -63.3 % +10.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.3M shares +3.59%
Common Stock, Shares, Outstanding 50.9M shares +3.68%
Entity Public Float 244M USD -19.2%
Common Stock, Value, Issued 51K USD +4.08%
Weighted Average Number of Shares Outstanding, Basic 50.1M shares +3.1%
Weighted Average Number of Shares Outstanding, Diluted 50.1M shares +3.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 79.9M USD -1.47%
Research and Development Expense 18M USD +2.48%
Operating Income (Loss) -50.5M USD +11.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -51.3M USD +7.52%
Income Tax Expense (Benefit) 236K USD +115%
Net Income (Loss) Attributable to Parent -51.5M USD +7.27%
Earnings Per Share, Basic -1.03 USD/shares +9.65%
Earnings Per Share, Diluted -1.03 USD/shares +9.65%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120M USD -12.9%
Accounts Receivable, after Allowance for Credit Loss, Current 10.8M USD -24.5%
Inventory, Net 6.33M USD -19.4%
Assets, Current 140M USD -14.2%
Property, Plant and Equipment, Net 1.58M USD -3.66%
Operating Lease, Right-of-Use Asset 935K USD -35.9%
Other Assets, Noncurrent 550K USD -19.4%
Assets 143M USD -14.3%
Accounts Payable, Current 1.69M USD -2.31%
Employee-related Liabilities, Current 9.68M USD +114%
Accrued Liabilities, Current 2.11M USD +28.9%
Liabilities, Current 15.5M USD +26.2%
Operating Lease, Liability, Noncurrent 473K USD -48.2%
Other Liabilities, Noncurrent 492K USD -80.1%
Liabilities 55.3M USD +19.1%
Retained Earnings (Accumulated Deficit) -346M USD -17.5%
Stockholders' Equity Attributable to Parent 87.5M USD -27.2%
Liabilities and Equity 143M USD -14.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.79M USD +43.7%
Net Cash Provided by (Used in) Financing Activities -942K USD -504%
Net Cash Provided by (Used in) Investing Activities -117K USD +7.14%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 50.9M shares +3.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.8M USD +38.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120M USD -12.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.05M USD +5.19%
Deferred Tax Assets, Valuation Allowance 87.7M USD +17.4%
Deferred Tax Assets, Gross 87.9M USD +17.2%
Operating Lease, Liability 1.01M USD -32.3%
Depreciation 500K USD -16.7%
Payments to Acquire Property, Plant, and Equipment 117K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 1.12M USD -35%
Property, Plant and Equipment, Gross 3.69M USD +12.8%
Operating Lease, Liability, Current 533K USD -6.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 497K USD -9.31%
Lessee, Operating Lease, Liability, to be Paid, Year One 618K USD -11.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 109K USD -52.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 497K USD
Deferred Tax Assets, Operating Loss Carryforwards 69.1M USD +13.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.28M USD +41.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 741K USD -36%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 192K USD +31.5%
Deferred Tax Assets, Net of Valuation Allowance 244K USD -36%
Share-based Payment Arrangement, Expense 17.1M USD +17.1%
Interest Expense 4.66M USD -13.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%